Argus group appoints Miranthis and Curran to board of directors
Argus Group Holdings has appointed Constantinos “Costas” Miranthis and Garrett Curran to its board of directors. Both appointments were effective as of April 12, 2021.
Miranthis, a re/insurance industry veteran, is a former president and CEO of PartnerRe. He is a non-executive director of specialty insurer Hiscox and of Pacific Life Re.
Curran is an adviser and investor specialising in financial services, technology and real estate. He is managing director of Equilibria Capital Management, Madrid, and sits on a number of boards, including that of Santander UK as a non-executive director. Curran spent more than 20 years in investment banking in a variety of positions in London and New York. Most recently, he was CEO of Credit Suisse in the UK and the bank’s chief client officer in the Europe, Middle East and Africa (EMEA) region, while also managing and supervising their Global Markets EMEA client business.
“I am very pleased to welcome Costas and Garrett to the Argus board,” said chairman David Brown. “They bring a wealth of experience as well as expertise in the re/insurance and financial services sectors. As Argus continues to implement its strategy for sustainable, profitable growth, Costas’ and Garrett’s respective backgrounds will enable them both to play key roles in moving these strategies forward.”
Chief executive officer Alison Hill added: “As part of our future vision, we continue to be focused on improving shareholder value by undertaking strategies that will enhance the future growth, diversification and resilience of Argus’ earnings,” said “We also remain committed to reinvesting in the business – balancing profitability, risk, growth and strategic investments for the long-term benefit of our shareholders, employees and business partners.”
Did you get value from this story? Sign up to our free daily newsletters and get stories like this sent straight to your inbox.
Already registered?
Login to your account
If you don't have a login or your access has expired, you will need to purchase a subscription to gain access to this article, including all our online content.
For more information on individual annual subscriptions for full paid access and corporate subscription options please contact us.
To request a FREE 2-week trial subscription, please signup.
NOTE - this can take up to 48hrs to be approved.
For multi-user price options, or to check if your company has an existing subscription that we can add you to for FREE, please email Elliot Field at efield@newtonmedia.co.uk or Adrian Tapping at atapping@newtonmedia.co.uk
Editor's picks
Editor's picks
More articles
Copyright © intelligentinsurer.com 2024 | Headless Content Management with Blaze